Abstract
The rapid expansion in the past two decades in the understanding of the molecular basis of a large variety of novel congenital immunodeficiencies has provided valuable information on the signal transduction general mechanisms, that goes far beyond the comprehension of the individual disease. In most cases, the altered molecules are exclusively expressed in haematopoietic cells, while in other cases they are not restricted to a certain cell type. This leads to more complex clinical phenotypes, which contribute to unravel previously unappreciated non-haematopoietic functions of signaling proteins and the mechanism of coordination and integration of several pathways. Moreover, this knowledge will help define potential new therapeutic strategies through novel molecular targets, drive stem cell development into the desired differentiation path and ameliorate our comprehension of tissue engineering. This review focuses on the multiple roles in haematopoietic and non-haematopoietic receptors of the gamma signaling element with a special attention paid to the participation of gamma to growth hormone receptor signaling, confirming the presence of an interplay between endocrine and immune system.
Keywords: Congenital immunodeficiencies, growth hormone receptor, signal transduction, gamma chain, STATs
Current Signal Transduction Therapy
Title: Shared Signaling Pathways Between Endocrine and Immune System Receptors: The Model of Gamma Chain
Volume: 3 Issue: 3
Author(s): Claudio Pignata, Stefania Amorosi, Ilaria Russo, Donatella Capalbo, Teresa Lettiero, Marsilio Adriani and Mariacarolina Salerno
Affiliation:
Keywords: Congenital immunodeficiencies, growth hormone receptor, signal transduction, gamma chain, STATs
Abstract: The rapid expansion in the past two decades in the understanding of the molecular basis of a large variety of novel congenital immunodeficiencies has provided valuable information on the signal transduction general mechanisms, that goes far beyond the comprehension of the individual disease. In most cases, the altered molecules are exclusively expressed in haematopoietic cells, while in other cases they are not restricted to a certain cell type. This leads to more complex clinical phenotypes, which contribute to unravel previously unappreciated non-haematopoietic functions of signaling proteins and the mechanism of coordination and integration of several pathways. Moreover, this knowledge will help define potential new therapeutic strategies through novel molecular targets, drive stem cell development into the desired differentiation path and ameliorate our comprehension of tissue engineering. This review focuses on the multiple roles in haematopoietic and non-haematopoietic receptors of the gamma signaling element with a special attention paid to the participation of gamma to growth hormone receptor signaling, confirming the presence of an interplay between endocrine and immune system.
Export Options
About this article
Cite this article as:
Pignata Claudio, Amorosi Stefania, Russo Ilaria, Capalbo Donatella, Lettiero Teresa, Adriani Marsilio and Salerno Mariacarolina, Shared Signaling Pathways Between Endocrine and Immune System Receptors: The Model of Gamma Chain, Current Signal Transduction Therapy 2008; 3 (3) . https://dx.doi.org/10.2174/157436208785699695
DOI https://dx.doi.org/10.2174/157436208785699695 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recombinant Murine Polyoma Virus-like-particles Induce Protective Antitumour Immunity
Letters in Drug Design & Discovery Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases
Current Pharmaceutical Design Contrast Functions of αA- and αB-Crystallins in Cancer Development
Current Molecular Medicine Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Healing Effects of Curcumin Nanoparticles in Deep Tissue Injury Mouse Model
Current Drug Delivery Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment
Current Genomics Curcumin Therapeutic Modulation of the Wnt Signaling Pathway
Current Pharmaceutical Biotechnology Actions of the Anti-Angiogenic Compound Angiostatin in an Animal Model of Alzheimer’s Disease
Current Alzheimer Research Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology
Current Drug Discovery Technologies Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Fast Determination of β-estradiol by Chromatographic Method and its Application to Clinical Pharmacokinetics Studies
Current Pharmaceutical Analysis Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Ketogenic Diet Acts on Body Remodeling and MicroRNAs Expression Profile
MicroRNA Chondroitin Sulfate and Sulfur Containing Chondroprotective Agents: Is there a Basis for their Pharmacological Action?
Current Rheumatology Reviews The Peptide Argireline-The Importance of Local Application on the Skin, in the Light of Current Knowledge
Letters in Drug Design & Discovery Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases
Current Protein & Peptide Science Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
Current Topics in Medicinal Chemistry RGD Peptide–mediated Molecular Imaging for Targeting Integrin Alpha(v) Beta(3) in Tumors: A Review
Current Medical Imaging